| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Research Abstract |
We conducted proteomics approaches to discover novel biomarkers of bone and soft tissue tumors. Also, we tried to validate possibilities of the biomarker and the functions of the proteins in the each tumors for developing clinical applications. In this project, we focused on GIST, Ewing sarcoma, synovial sarcoma, osteosarcoma as well as giant cell tumor. In the results, we identified several proteins was candidates of biomarkers and have succeeded to confirm the power of biomarker in the each larger scale validation using multi-institutional cohorts. Also we also illuminated the functions of these proteins in the each tumors based on cell proliferation, interactive proteins, regulated proteins..
|
